WHO Favors Lifestyle Changes Over GLP-1 Drugs for Childhood Obesity | Retatrutide News

The WHO recommends lifestyle changes over GLP-1 drugs for childhood obesity management. This may impact the development of drugs like retatrutide.
Market News · October 12, 2026